Eric Hsu

2023

In 2023, Eric Hsu earned a total compensation of $260.5K as Senior Vice President, Preclinical Research & Development at InMed Pharmaceuticals, a 8% decrease compared to previous year.

Compensation breakdown

Bonus$38,000
Option Awards$5,500
Salary$217,000
Total$260,500

Hsu received $217K in salary, accounting for 83% of the total pay in 2023.

Hsu also received $38K in bonus and $5.5K in option awards.

Rankings

In 2023, Eric Hsu's compensation ranked 2,484th out of 2,770 executives tracked by ExecPay. In other words, Hsu earned more than 10.3% of executives.

ClassificationRankingPercentile
All
2,484
out of 2,770
10th
Division
Manufacturing
1,375
out of 1,516
9th
Major group
Chemicals And Allied Products
796
out of 855
7th
Industry group
Drugs
774
out of 821
6th
Industry
Pharmaceutical Preparations
552
out of 590
6th
Source: SEC filing on October 28, 2024.

Hsu's colleagues

We found four more compensation records of executives who worked with Eric Hsu at InMed Pharmaceuticals in 2023.

2023

Eric Adams

InMed Pharmaceuticals

Chief Executive Officer

2023

Michael Woudenberg

InMed Pharmaceuticals

Chief Operating Officer

2023

Alexandra Mancini

InMed Pharmaceuticals

Senior Vice President, Clinical & Regulatory Affairs

2023

Jonathan Tegge

InMed Pharmaceuticals

Chief Financial Officer

News

You may also like